Switch theme
Sign up to access all valuation multiples
Fevertree Drinks PLC is a UK based holding and investment company. The company is engaged in the business activity of developing and marketing premium mixer drinks. Its product portfolio includes Indian tonic water, Mediterranean tonic water, Elderflower tonic water, Aromatic tonic water, Clementine tonic water, Lemon tonic water, Ginger beer, Ginger ale, Smoky ginger ale, Spiced orange ginger ale, Madagascan cola, Sicilian lemonade, Lemonade, Premium Soda Water and Mediterranean Orange. The company operates in the UK, USA, Europe, and other countries, of which most of the revenue is from the United Kingdom.
2013
375
LTM Revenue $478M
LTM EBITDA $63.5M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Fever-Tree has a last 12-month revenue of $478M and a last 12-month EBITDA of $63.5M.
In the most recent fiscal year, Fever-Tree achieved revenue of $469M and an EBITDA of $39.7M.
Fever-Tree expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Fever-Tree valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $443M | $469M | XXX | XXX | XXX |
| Gross Profit | $169M | $153M | XXX | XXX | XXX |
| Gross Margin | 38% | 33% | XXX | XXX | XXX |
| EBITDA | $47.9M | $39.7M | XXX | XXX | XXX |
| EBITDA Margin | 11% | 8% | XXX | XXX | XXX |
| Net Profit | $57.4M | $32.1M | XXX | XXX | XXX |
| Net Margin | 13% | 7% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Fever-Tree's stock price is GBP 8 (or $10).
Fever-Tree has current market cap of GBP 962M (or $1.2B), and EV of GBP 878M (or $1.1B).
See Fever-Tree trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $1.2B | XXX | XXX | XXX | XXX | $0.35 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Fever-Tree has market cap of $1.2B and EV of $1.1B.
Fever-Tree's trades at 2.4x LTM EV/Revenue multiple, and 17.8x LTM EBITDA.
Analysts estimate Fever-Tree's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Fever-Tree and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.1B | XXX | XXX | XXX |
| EV/Revenue | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | 28.5x | XXX | XXX | XXX |
| P/E | 62.5x | XXX | XXX | XXX |
| P/E/Growth | 1.3x | XXX | XXX | XXX |
| EV/FCF | -65.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpFever-Tree's NTM/LTM revenue growth is 5%
Fever-Tree's revenue per employee for the last fiscal year averaged $1.3M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Fever-Tree's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Fever-Tree's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Fever-Tree and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -17% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 13% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 26% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 26% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Agthia Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Acomo | XXX | XXX | XXX | XXX | XXX | XXX |
| ForFarmers | XXX | XXX | XXX | XXX | XXX | XXX |
| JDE Peets | XXX | XXX | XXX | XXX | XXX | XXX |
| Sligro Food Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fever-Tree acquired XXX companies to date.
Last acquisition by Fever-Tree was XXXXXXXX, XXXXX XXXXX XXXXXX . Fever-Tree acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Fever-Tree founded? | Fever-Tree was founded in 2013. |
| Where is Fever-Tree headquartered? | Fever-Tree is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Fever-Tree have? | As of today, Fever-Tree has 375 employees. |
| Who is the CEO of Fever-Tree? | Fever-Tree's CEO is Mr. Timothy Daniel Gray Warrillow. |
| Is Fever-Tree publicy listed? | Yes, Fever-Tree is a public company listed on LON. |
| What is the stock symbol of Fever-Tree? | Fever-Tree trades under FEVR ticker. |
| When did Fever-Tree go public? | Fever-Tree went public in 2014. |
| Who are competitors of Fever-Tree? | Similar companies to Fever-Tree include e.g. Agthia Group, Acomo, ForFarmers, JDE Peets. |
| What is the current market cap of Fever-Tree? | Fever-Tree's current market cap is $1.2B |
| What is the current revenue of Fever-Tree? | Fever-Tree's last 12-month revenue is $478M. |
| What is the current EBITDA of Fever-Tree? | Fever-Tree's last 12-month EBITDA is $63.5M. |
| What is the current EV/Revenue multiple of Fever-Tree? | Current revenue multiple of Fever-Tree is 2.4x. |
| What is the current EV/EBITDA multiple of Fever-Tree? | Current EBITDA multiple of Fever-Tree is 17.8x. |
| What is the current revenue growth of Fever-Tree? | Fever-Tree revenue growth between 2023 and 2024 was 6%. |
| Is Fever-Tree profitable? | Yes, Fever-Tree is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
